Topical application of JAK1/JAK2 inhibitor momelotinib exhibits significant anti-inflammatory responses in DNCB-induced atopic dermatitis model mice - Jin, W; Huang, W; Chen, L; Jin, M; Wang, Q; Gao, Z; Jin, Z (Int J Mol Sci, 2018)